Biomarkers


Overview

A biomarker is a biologic specimen that may be a marker of exposure to a substance, its metabolism, or an integration of exposure and metabolism. Biomarkers may also reflect host characteristics. Because biomarkers are sometimes related to risk of disease, they are important in cancer control research.

EGRP is interested in understanding how biomarkers can be used in early detection/screening of cancer, identifying environmental exposures that may lead to cancer, and as markers of nutrition that either promote or protect against cancer.

Return to Top

Funding Opportunities

NCI is currently sponsoring the following Funding Opportunity Announcements (FOAs) for biomarkers research:

  • Assay Validation for High Quality Markers for NCI-Supported Clinical Trials - expires July 9, 2018
  • Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival - expires September 8, 2018, unless reissued

EGRP joins with other NCI Divisions, Offices, and Centers and other Institutes and Centers at the National Institutes of Health (NIH) to fund grant applications submitted in response to FOAs. View the full list of EGRP FOAs.

EGRP also encourages investigator-initiated grant applications on topics related to biomarkers and cancer epidemiology.

Return to Top

Research Resources

Return to Top

Selected Publications

Return to Top

Workshops and Meetings

Return to Top

EGRP Contacts

Return to Top